thalidomide has been researched along with Anaplastic Oligodendroglioma in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olisova, OY | 1 |
| Anpilogova, EM | 1 |
| Svistunova, DA | 1 |
| Burton, E | 1 |
| Prados, M | 1 |
1 review available for thalidomide and Anaplastic Oligodendroglioma
| Article | Year |
|---|---|
New chemotherapy options for the treatment of malignant gliomas.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Camptothecin; Clinical Trials as Topic; Dacarbazine; | 1999 |
1 other study available for thalidomide and Anaplastic Oligodendroglioma
| Article | Year |
|---|---|
Apremilast as a potential treatment option for COVID-19: No symptoms of infection in a psoriatic patient.
Topics: Arthritis, Psoriatic; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Care; Humans; Infe | 2020 |